Center on Democracy, Development, and the Rule of Law
Center for International Security and Cooperation
Center on Food Security and the Environment
Stanford Health Policy
The Europe Center
Walter H. Shorenstein Asia-Pacific Research Center
Program on Energy and Sustainable Development
Rural Education Action Program
Stanford Program on International and Cross-Cultural Education
Inter-University Center for Japanese Language Studies
Ford Dorsey Program in International Policy Studies
Center for Innovation in Global Health
Stanford Center at Peking University
About CISAC
Mailing List
@StanfordCISAC
Facebook
People
MagnifyAlan M. Garber, MD, PhD
Provost of Harvard University, Mallinckrodt Professor of Health Care Policy at Harvard Medical School and a Professor of Economics in the Harvard Kennedy School of Government and the Faculty of Arts and Sciences and Former Stanford Health Policy Director; Henry J. Kaiser, Jr. Professor Emeritus
Office of the President and Provost
Massachusetts Hall
11 Harvard Yard
Cambridge, MA 02138-6504
email is private
Research Interests
health screening programs; health care of the elderly; methods of cost-effectiveness and cost-benefit analysis; health expenditure growth; international comparisons of healthcare financing and delivery; evaluation of new healthcare technologies; improving processes for making medical decisions
View Alan Garber's bio, list of research, recent publications and events »
Reports
Comparative Effectiveness Research Prioritization
Institute of Medicine's Committee on Comparative Effectiveness Research Prioritization, Alan M. Garber
Institute of Medicine's Committee on Comparative Effectiveness Research Prioritization (2009)
- Quality of Life Assessment Designed for Computer Inexperienced Older Adults: Multimedia Utility Elicitation for Activities of Daily Living
Mary K. Goldstein, David E. Miller, Sheryl M. Davies, Alan M. Garber
Proceedings of the American Medical Informatics Association's Annual Symposium 2002 (2002) - Cost-Effectiveness of Diagnosis and Screening for Coronary Artery Disease with Electron Beam Computed Tomography
A Hwang, A Brown, Alan M. Garber
Blue Cross-Blue Shield Association, TEC Special Assessment vol. 14 (2000) - Relative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostate Cancer
J. Seidenfeld, D.J. Samson, N. Aronson, P.C. Albertson, A.M. Bayoumi, C. Bennett, A. Brown, Alan M. Garber, M. Gere, V. Hasselblad
Evidence Report/Technology Assessment No. 4. (Prepared by Blue Cross/Blue Shield Association Evidence-based Practice Center under Contract NO. 290-97-0015). AHCPR Publication # 99-EE0012. Rockville, Maryland: Agency for Health Care Policy and Researc (1999) - Outpatient Pulmonary Rehabilitation for Chronic Obstructive Lung Disease: Cost-Effectiveness Analysis
Alan M. Garber, A.D. Brown
Medical Advisory Panel, TEC Program, Blue Cross Blue Shield Association (1997) - Positron Emission Tomography Myocardial Perfusion Imaging for the Detection of Coronary Artery Disease
Neil Solomon, Alan M. Garber
Medical Advisory Panel, TEC Program, Blue Cross Blue Shield Association. (1995) 
Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease
Alan M. Garber, A.E. Clark, D.P. Goldman, M.E. Gluck
Washington, D.C.: U.S. Government Printing Office (1992)- Testimony on Cholesterol
Alan M. Garber
Washington, D.C.: U.S. Government Printing Office (1989) - Costs and Effectiveness of Cholesterol Screening in the Elderly
Alan M. Garber, B. Littenberg, H.C. Sox Jr., M.E. Gluck, J.L. Wagner, B.M. Duffy
Washington, DC: U.S. Government Printing Office (GPO Stock Number: 052-003-01151-4) (1989) - Costs and Control of Antibiotic Resistance
Alan M. Garber
Department of Economics, Harvard University, Cambridge, Massachusetts (1982)
Journal Articles
- Knowing loved ones' end-of-life health care wishes: Attachment security predicts caregivers' accuracy
Turan B, Mary K. Goldstein, Alan M. Garber, Carstensen LL
Health Psychology vol. 30, 6 (2011) 
How CER Could Pay for Itself: Insights from Vertebral Fracture Treatments
Adam G. Elshaug, Alan M. Garber
New England Journal of Medicine (2011)- The Behavioural Economics of Exercise Habits
Jeremy Goldhaber-Fiebert, Alan M. Garber
VoxEU (2011) 
Desalination of the American Diet: Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease
Crystal Smith-Spangler, Jessie L. Juusola, Eva A. Enns, Douglas K. Owens, Alan M. Garber
Annals of Internal Medicine (2010)
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
James Freeman, Ruo Zhu, Douglas K. Owens, Alan M. Garber, David Hutton, Alan Go, Paul Wang, Mintu Turakhia
Annals of Internal Medicine (2010)- The Potential Impact of Comparative Effectiveness Research on U.S. Health Care Expenditures
Daniella Perlroth, Goldman DP, Alan M. Garber
Demography vol. 47, supplement (2010) 
- The role of costs in comparative effectiveness research
Alan M. Garber, Sox HC
Health Affairs vol. 29, 10 (2010) - Response letter: Population Strategies to Decrease Sodium Intake
Crystal Smith-Spangler, Douglas K. Owens, Alan M. Garber
Annals of Internal Medicine vol. 153, 4 (2010) - Incidental Extracardiac Findings at Coronary CT: Clinical and Economic Impact
Lee CI, Tsai EB, Sigal BM, Sylvia K. Plevritis, Alan M. Garber, Rubin G
American Journal of Roentgenology vol. 194, 6 (2010) - Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States.
Daniella Perlroth, Glass RJ, Davey VJ, Cannon D, Alan M. Garber, Douglas K. Owens
Clinical Infectious Diseases vol. 50, 2 (2010) 
Following Your Heart or Your Head: Focusing on Emotions versus Information Differentially Influences the Decisions of Younger and Older Adults
Joseph A. Mikels, Lockenhoff CE, Maglio SJ, Laura L. Carstensen, Mary K. Goldstein, Alan M. Garber
Journal of Experimental Psychology Applied vol. 16, 1 (2010)- Modernizing Device Regulation
Alan M. Garber
New England Journal of Medicine (2010) 
Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease: A Cost-Effectiveness Analysis
Crystal Smith-Spangler, Juusola JL, Enns EA, Douglas K. Owens, Alan M. Garber
Annals of Internal Medicine vol. 152, 5 (2010)- Health Outcomes and Costs of Community Mitigation Strategies for an Influenza Pandemic in the United States
Daniella Perlroth, Glass RJ, Davey VJ, Cannon D, Alan M. Garber, Douglas K. Owens
Clinical Infectious Diseases vol. 50 (2010) - Cost-Effectiveness of Alternative Imaging Strategies for the Diagnosis of Small-bowel Crohn's Disease
Barrett Levesque, Cipriano LE, Chang SL, Lee KK, Douglas K. Owens, Alan M. Garber
Clinical Gastroenterology and Hepatology vol. epub (2009) 
The Confirmatory Trial in Comparative-Effectiveness Research
Alan M. Garber, Mark A. Hlatky
New England Journal of Medicine vol. 361 (2009)- Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009
Nayer Khazeni, Hutton DW, Alan M. Garber, Hupert N, Douglas K. Owens
Annals of Internal Medicine vol. 151, 12 (2009) 
Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic
Nayer Khazeni, Hutton DW, Alan M. Garber, Douglas K. Owens
Annals of Internal Medicine vol. 151, 12 (2009)- Laparoscopy in Women with Unexplained Infertility: A Cost-Effectiveness Analysis
Sharon E. Moayeri, Lee, HC, Lathi, RB, Westphal LM, Miliki AA, Alan M. Garber
Fertility and Sterility vol. 92, 2 (2009) - Does Comparative-Effectiveness Research Threaten Personalized Medicine?
Alan M. Garber, Sean R. Tunis
New England Journal of Medicine vol. 360, 19 (2009) - An Uncertain Future for Cardiovascular Drug Development?
Alan M. Garber
New England Journal of Medicine vol. 360, 12 (2009) - Toward a 21st-Century Health Care System: Recommendations for Health Care Reform
Kenneth J. Arrow, Auerbach A, Bertko J, Brownlee S, Casalino LP, Cooper J, Crosson J, Alain C. Enthoven, Falcone E, Feldman RC, Victor R. Fuchs, Alan M. Garber, Gold MR, Goldman D, Hadfield GK, Hall MA, Horwitz RI, Hooven M, Jacobson PD, Stoltzfus Jost T, Kotlikoff LJ, Levin J, Levine S, Levy R, Linscott K, Harold S. Luft, Marshal R, McFadden D, Mechanic D, Meltzer D, Newhouse JP, Noll RG, Pietzsch JB, Pizzo P, Reischauer RD, Rosenbaum S, Sage W, Schaeffer LD, Sheen E, Siilber BM, Skinner J, Stephen M. Shortell, Thier SO, Sean R. Tunis, Wulsin L, Yock P, Nun GB, Stirling Bryan, Luxenburg O, van de Ven PMM
Annals of Internal Medicine vol. 150, 7 (2009) - Is American Health Care Uniquely Inefficient?
Alan M. Garber, Skinner J
Journal of Economic Perspectives vol. 22, 4 (2008) - Systematic Review: The Effects of Growth Hormone on Athletic Performance
Hau Liu, Dena M. Bravata, Ingram Olkin, Roberts B, Eran Bendavid, Olga Saynina, Salpeter SR, Alan M. Garber, Hoffman AR
Annals of Internal Medicine vol. 148, 10 (2008) - A Menu Without Prices
Alan M. Garber
Annals of Internal Medicine vol. 148, 12 (2008) - Is Having More Preapproval Data the Best Way to Assure Drug Safety?
Alan M. Garber
Health Affairs vol. 27, 5 (2008) - Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment.
Tamara L. Sims, Holmes TH, Dena M. Bravata, Alan M. Garber, Lorene Nelson, Mary K. Goldstein
Journal of Clinical Epidemiology vol. 61, 12 (2008) - Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis.
Amar Desai, Baras J, Berk B, Nakajima A, Alan M. Garber, Douglas K. Owens, Glenn M. Chertow
Archives of Internal Medicine vol. 168, 16 (2008) 
Influence of Race on Inpatient Treatment Intensity at the End of Life
AE Barnato, CC Chang, O Saynina, Alan M. Garber
Journal of General Internal Medicine vol. 22, 3 (2007)
Rise of Pay for Performance: Implications for Care of People with Chronic Kidney Disease
Amar Desai, Alan M. Garber, GM Chertow
Clinical Journal of the American Society of Nephrology (2007)
Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu-Positive Breast Cancer, A
AW Kurian, RN Thompson, AF Gaw, S Arai, R Ortiz, Alan M. Garber
Journal of Clinical Oncology vol. 25, 6 (2007)
Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly
Hau Liu, Dena M. Bravata, Ingram Olkin, Smita Nayak, Brian Roberts, Alan M. Garber, Andrew Hoffman
Annals of Internal Medicine vol. 146, 2 (2007)
The Price of Growth in the Medical-Device Industry
Alan M. Garber
New England Journal of Medicine vol. 355, 4 (2006)
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
Sylvia K. Plevritis, AW Kurian, BM Sigal, BL Daniel, DM Ikeda, FE Stockdale, Alan M. Garber
Journal of the American Medical Association vol. 295, 20 (2006)
To Use Technology Better
Alan M. Garber
Health Affairs vol. 25, 2 (2006)
The Cost-effectiveness of Therapy With Teriparatide and Alendronate in Women With Severe Osteoporosis
Hau Liu, Kaleb D. Michaud, Smita Nayak, David Karpf, Douglas K. Owens, Alan M. Garber
Archives of Internal Medicine vol. 166, 11 (2006) 
Effect of Geriatrics Evaluation and Management on Nursing Home Use and Health Care Costs: Results From a Randomized Trial
Ciaran S. Phibbs, Jon-Erik Holty, Mary K. Goldstein, Alan M. Garber, Y Wang, JR Feussner, HJ Cohen
Medical Care vol. 44, 1 (2006)- Consequences of health trends and medical innovation for the future elderly
Goldman, D.P., Shang, B., Jay Bhattacharya, Alan M. Garber, Hurd, M., Joyce, G. F., Lakdawalla DN, Panis C, Shekelle PG
Health Affairs (Project Hope) vol. 24 Suppl 2 (2005) 
Cost-Effectiveness of Defending against Bioterrorism: A Comparison of Vaccination and Antibiotic Prophylaxis against Anthrax
RA Fowler, Gillian D. Sanders, Dena M. Bravata, B Nouri, JM Gastwirth, D Peterson, AG Broker, Alan M. Garber, Douglas K. Owens
Annals of Internal Medicine vol. 142, 8 (2005)
Invariance and Inconsistency in Utility Ratings
Dena M. Bravata, LM Nelson, Alan M. Garber, Mary K. Goldstein
Medical Decision Making vol. 25 (2005)
Technology Diffusion, Hospital Variation, and Racial Disparities Among Elderly Medicare Beneficiaries: 1989-2000
Peter W. Groeneveld, Sara B. Laufer, Alan M. Garber
Medical Care vol. 43, 4 (2005)
Evidence-based Guidelines as a Foundation for Performance Incentives
Alan M. Garber
Health Affairs vol. 24, 1 (2005).jpg)
Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography
P Groeneveld, Paul A. Heidenreich, Alan M. Garber
Journal of the American College of Cardiology vol. 45, 1 (2005).jpg)
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life
AE Barnato, Mark B. McClellan, CR Kagay, Alan M. Garber
Health Services Research vol. 39, 2 (2004).jpg)
Impacts of informal caregiver availability on long-term care expenditures in OECD countries
Byung-Kwang (BK) Yoo, Jay Bhattacharya, Kathryn M. McDonald, Alan M. Garber
Health Services Research vol. 39, 6 (2004)
Health Plans' Coverage Determinations for Technology-based Interventions: The Case of Electrical Bone Growth Stimulation
A Huang, M Gemperli, Linda A. Bergthold, Sara J. Singer, Alan M. Garber
The American Journal of Managed Care vol. 10 (2004)
U.S. Physician Workforce: Serious Questions Raised, Answers Needed
Alan M. Garber, Harold S. Sox
Annals of Internal Medicine vol. 141, 9 (2004)
Corporate Treatment for the Ills of Academic Medicine
Alan M. Garber
New England Journal of Medicine vol. 351, 16 (2004).jpg)
Costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans, The
Buntin MB, Alan M. Garber, Mark B. McClellan, Newhouse JP
Health Services Research vol. 39, 1 (2004)
Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis
Fowler RA, Hill-Popper M, Petrou C, Stasinos J, Gillian D. Sanders, Alan M. Garber
Journal of Critical Care vol. 18, 3 (2003)
Racial Disparity in Cardiac Procedures and Mortality among Long-Term Survivors of Cardiac Arrest
Pete Groeneveld, Paul A. Heidenreich, Alan M. Garber
Circulation vol. 108, 3 (2003)
Quality-of-Life Ratings for Health States of Dependency in Activities of Daily Living
Mary K. Goldstein, M. Mather, Pam Mahlow, Alan M. Garber
Journal of the American Geriatrics Society vol. 51, 4 (2003)
Cost-effectiveness of Bypass Surgery versus Stenting in Patients with Multivessel Coronary Artery Disease
Cynthia A. Yock, Derek B. Boothroyd, Douglas K. Owens, Alan M. Garber, Mark A. Hlatky
American Journal of Medicine vol. 115 (2003)- Medical Innovation: Promise and Pitfalls
Victor R. Fuchs, Alan M. Garber
Brookings Review (2003) 
Trends in Hospital Treatment of Ventricular Arrhythmias among Medicare Beneficiaries, 1985-1995
Kathryn M. McDonald, Mark A. Hlatky, O Saynina, Jeffrey J. Geppert, Alan M. Garber, Mark B. McClellan
American Heart Journal vol. 144, 3 (2002)
Perinatal Screening of Group B Streptococci: Cost-Benefit Analysis of Rapid Polymerase Chain Reaction
Corinna Haberland, WE Benitz, Gillian D. Sanders, JB Pietzsch, S Yamada, L Nguyen, Alan M. Garber
Pediatrics vol. 110, 3 (2002)
Utilization and Outcomes of the Implantable Cardioverter Defibrillator: 1987-1995
Mark A. Hlatky, O Saynina, Kathryn M. McDonald, Alan M. Garber, Mark B. McClellan
American Heart Journal vol. 144, 3 (2002).jpg)
Cost-Effectiveness of Automated External Defibrillators on US Airlines, The
Pete Groeneveld, JL Kwong, Y Liu, AJ Rodriguez, MP Jones, Gillian D. Sanders, Alan M. Garber
Journal of the American Medical Association vol. 286, 12 (2001)
Evidence-Based Coverage Policy
Alan M. Garber
Health Affairs vol. 20, 5 (2001)
Current Approaches to Cervical Cancer Screening
GF Sawaya, AD Brown, AE Washington, Alan M. Garber
New England Journal of Medicine (2001).jpg)
Cost-Effectiveness of Androgen Suppression Strategies in Advanced Prostate Cancer
A.M. Bayoumi, A.D. Brown, Alan M. Garber
J Natl Cancer Inst vol. 92 (2000)
Using Cost-Effectiveness Analysis to Target Cholesterol Reduction
Alan M. Garber
Annals of Internal Medicine vol. 132 (2000)
Cost-Effectiveness Analysis of Prescribing Strategies in Managing Gastroesophageal Reflux Disease, A
LB Gerson, AS Robbins, Alan M. Garber, J Hornberger, GT Triadafilopoulos
American Journal of Gastroenterology vol. 95 (2000)
Realistic Rigor in Cost-Effectiveness Methods
Alan M. Garber
Medical Decision Making vol. 19 (1999)
Low Molecular Weight Heparins Compared with Unfractionated Heparin for the Treatment of Acute Deep Vein Thrombosis: A Cost-Effectiveness Analysis
Michael K. Gould, Anne Dembitzer, Gillian D. Sanders, Alan M. Garber
Annals of Internal Medicine vol. 130 (1999)
Cost-Effectiveness of Alternative Test Strategies for the Diagnosis of Coronary Artery Disease
Alan M. Garber, N.A. Solomon
Annals of Internal Medicine vol. 130 (1999).jpg)
Cost-Effectiveness of Three Methods to Enhance the Sensitivity of Papanicolaou Testing
AD Brown, Alan M. Garber
Journal of the American Medical Association vol. 281 (1999)
Effect of Search Procedures on Utility Elicitations
L Lenert, D Cher, Mary K. Goldstein, Merlynn R. Bergen, Alan M. Garber
Medical Decision Making vol. 18 (1998)
Effect of Search Procedures on Utility Elicitations, The
L.A. Lenert, D.J. Cher, Mary K. Goldstein, Merlynn R. Bergen, Alan M. Garber
Medical Decision Making vol. 18 (1998)
Cost-Effectiveness and Cost Benefit Analysis of Using Methotrexate Vs. Goeckerman Therapy for Psoriasis
S Chen, A Shaheen, Alan M. Garber
Archives of Dermatology vol. 134 (1998)
Polymerase Chain Reaction for the Diagnosis of HIV Infection in Adults
Douglas K. Owens, M. Holodniy, Alan M. Garber
Annals of Internal Medicine vol. 126 (1997)
Effect of Assessment Method and Respondent Population on Utilities Elicited for Gaucher Disease, The
AE Clarke, Mary K. Goldstein, D Michelson, Alan M. Garber, LA Lenert
Quality of Life Research vol. 6 (1997)
Measurement of the Validity of Utility Elicitations Performed by Computerized Interview
LA Lenert, S Morss, Merlynn R. Bergen, Mary K. Goldstein, WO Faustman, Alan M. Garber
Medical Care vol. 35 (1997)- Productivity Costs, Time Costs and Health-Related Quality of Life: A Response to the Erasmus Group
M.C. Weinstein, J.E. Siegel, Alan M. Garber, J. Lipscomb, B.R. Luce, W.G. Manning, G.W. Torrance
Health Economics vol. 6 (1997) 
Mortality, Hospital Admissions, and Medical Costs of End-Stage Renal Disease in the United States and Manitoba, Canada
JC Hornberger, Alan M. Garber, JR Jeffery
Medical Care vol. 35 (1997)
Economic Foundations of Cost-Effectiveness Analysis
Alan M. Garber, C.E. Phelps
Journal of Health Economics vol. 16 (1997)
Cost-Effectiveness of Screening for Carotid Stenosis in Asymptomatic Individuals
Tina Lee, NA Solomon, Paul A. Heidenreich, J Oehlert, Alan M. Garber
Annals of Internal Medicine vol. 126 (1997)
Cholesterol Screening Should Be Targeted
Alan M. Garber
American Journal of Medicine vol. 102(2A) (1997)
Cholesterol Screening Guidelines: Consensus, Evidence, and Common Sense
Alan M. Garber, W.S. Browner
Circulation vol. 95 (1997).jpg)
Cost-Effectiveness of Assessment and Management of Risk Factors
L. Goldman, Alan M. Garber, S. Grover, Mark A. Hlatky
J Am Coll Cardiol vol. 27 (1996)
Polymerase Chain Reaction for the Diagnosis of HIV Infection in Adults: A Meta-Analysis with Recommendations for Clinical Practice and Study Design, The
Douglas K. Owens, M Holodniy, Alan M. Garber, J Scott, S Sonnad, L Moses, B Kinosian, JS Schwartz
Annals of Internal Medicine vol. 124 (1996)
Cost of VA Sponsored Research, The
Paul G. Barnett, Alan M. Garber
Academic Medicine vol. 71, 10 (1996).jpg)
Task Force 6: Cost Effectiveness of Assessment and Management of Risk Factors
L. Goldman, Alan M. Garber, S.A. Grover, Mark A. Hlatky
Journal of the American College of Cardiology vol. 27 (1996)
Guidelines for Using Serum Cholesterol, High-Density Lipoprotein Cholesterol, and Triglycerides as Screening Tests for Preventing Coronary Heart Disease in Adults
Alan M. Garber, W.S. Browner
Annals of Internal Medicine vol. 124 (1996)
Evaluating the Federal Role in Financing Health-Related Research
Alan M. Garber, P.M. Romer
Proceedings of the National Academy of Sciences vol. 93 (1996)- Cost-Effectiveness Analysis as a Measure of Value
Alan M. Garber
Tecnologica. vol. 39 (1996) 
Cholesterol Screening in Asymptomatic Adults, Revisited
Alan M. Garber, W.S. Browner, S.B. Hulley
Annals of Internal Medicine vol. 124 (1996)- Cost of VA Sponsored Research: Modified Cost Allocation Method
Paul G. Barnett, Alan M. Garber
Center for Health Care Evaluation, Department of Veterans Affairs (1995) 
Problems with the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
TB Newman, Alan M. Garber, NA Holtzman, SB Hulley
Archives of Pediatrics & Adolescent Medicine vol. 149 (1995)
Workshop J: Prevention Strategies, Economic Realities, and Identification of Prevention Research Needs
M.C. Weinstein, Alan M. Garber, D.G. Fryback
Preventive Medicine vol. 23 (1994)- Predicting High-Risk Cholesterol Levels
Alan M. Garber, Richard A. Olshen, H. Zhang, E.S. Venkatraman
International Statistical Review, Previous version available as Technical Report No. 151, Division of Biostatistics, Stanford University, 1992. vol. 62 (1994) 
Developing and Testing a Multimedia Presentation of a Health State Description
Mary K. Goldstein, AE Clark, DJ Michelson, Alan M. Garber, Merlynn R. Bergen, LA Lenert
Medical Decision Making vol. 14 (1994)
Can Technology Assessment Control Health Spending?
Alan M. Garber
Health Affairs vol. 13, 3 (1994)
Benefits vs Profits: Has the Orphan Drug Act Gone Too Far?
Alan M. Garber
Pharmacoeconomics vol. 5 (1994)
Alglucerase for Gaucher's Disease: Dose, Costs, and Benefits
E Beutler, Alan M. Garber
PharmacoEconomics vol. 5 (1994).jpg)
Should We Be Measuring Blood Cholesterol Levels in Young Adults?
S.B. Hulley, T.B. Newman, D. Grady, Alan M. Garber, R.B. Baron, W.S. Browner
Journal of the American Medical Association vol. 269 (1993)- Nursing Home Discharges and Exhaustion of Medicare Benefits
Alan M. Garber, Thomas E. MaCurdy
Journal of the American Statistical Association vol. 88 (1993) - Is High-Flux Dialysis Cost Effective?
JC Hornberger, Alan M. Garber, M Chernew
International Journal of Technology Assessment in Health Care vol. 9 (1993) - Creating the Costliest Orphan: The Orphan Drug Act in the Development of Ceredase
AE Clarke, DP Goldman, Alan M. Garber
International Journal of Technology Assessment in Health Care vol. 8 (1992) 
Multivariate Analysis of Mortality and Hospital Admission Rates of High-Flux Dialysis, A
JC Hornberger, M Chernew, J Petersen, Alan M. Garber
Journal of the American Society of Nephrology vol. 3 (1992)- Expanding Role of Technology Assessment in Health Policy, The
Alan M. Garber, Victor R. Fuchs
Stanford Law & Policy Review vol. 3 (1991) 
Practice Guidelines and Cholesterol Policy
Alan M. Garber, J.L Wagner
Health Affairs vol. 10, 2 (1991)
Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older Americans
Alan M. Garber, B. Littenberg, H.C. Sox, J.L. Wagner, M. Gluck
Archives of Internal Medicine vol. 151 (1991)
Costs and Benefits of Prenatal Screening for Cystic Fibrosis
Alan M. Garber, J.P Fenerty
Medical Care vol. 29 (1991)
New Technology Assessment, The
Victor R. Fuchs, Alan M. Garber
New England Journal of Medicine vol. 323 (1990)
Screening for Hypertension
B. Littenberg, Alan M. Garber, H.C. Sox
Annals of Internal Medicine, Reprinted in Eddy DM, editor, Common Screening Tests, 22-46. Philadelphia: American College of Physicians, 1991 vol. 112 (1990)- Computer Program for Statistically-Based Decision Analysis, A
J.X. Polaschek, L.A. Lenert, Alan M. Garber
Proceedings of the Symposium on Computer Applications in Medical Care (1990) 
Where to Draw the Line against Cholesterol
Alan M. Garber
Annals of Internal Medicine vol. 111 (1989)
Role of Exercise Testing in Screening for Coronary Artery Disease, The
H.C. Sox, B. Littenberg, Alan M. Garber
Annals of Internal Medicine vol. 110 (1989)
Resting Electrocardiogram as a Screening Test: A Clinical Analysis, The
H.C. Sox, Alan M. Garber, B. Littenberg
Annals of Internal Medicine vol. 111 (1989)
Screening Asymptomatic Adults for Cardiac Risk Factors: The Serum Cholesterol Level
Alan M. Garber, H.C. Sox, B. Littenberg
Annals of Internal Medicine, Reprinted in Eddy DM, editor, Common Screening Tests, 113-153. Philadelphia: American College of Physicians, 1991 vol. 110 (1989)
Discrete-Time Model of the Acquisition of Antibiotic-Resistant Infections in Hospitalized Patients, A
Alan M. Garber
Biometrics vol. 45 (1989)
Cost-Containment and Financing the Long-Term Care of the Elderly
Alan M. Garber
Journal of the American Geriatrics Society vol. 36 (1988)
Antibiotic Exposure and Resistance in Mixed Bacterial Populations
Alan M. Garber
Theoretical Population Biology vol. 32 (1987)
Case Mix, Costs, and Outcomes: Differences between Faculty and Community Services in a University Hospital
Alan M. Garber, Victor R. Fuchs, J.F. Silverman
New England Journal of Medicine vol. 310 (1984)- Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis
Amar Desai, Baras J, Berk BB, Nakajima A, Alan M. Garber, Douglas K. Owens, Glenn M. Chertow
Arch Intern Med vol. 168, 16 
Cost-effectiveness and evidence evaluation as criteria for coverage policy
Alan M. Garber
Health Affairs
Books & Book Chapters
Biomedical Informatics: Computer Applications in Health Care and Biomedicine, 3rd Edition
EH Shortliffe, JJ Cimino, Alan M. Garber, Douglas K. Owens, Sara J. Singer, Alain C. Enthoven
Springer (2006)
Near-Universal Coverage Through Health Plan Competition: An Insurance Exchange Approach
Sara J. Singer, Alan M. Garber, Alain C. Enthoven
Washington DC: Economic and Social Research Institute in "Covering America: Real Remedies for the Uninsured", JA Meyer and EK Wicks, ed. (2001)
Trends in the Use of Intensive Procedures at the End of Life
AE Barnato, Alan M. Garber, CR Kagay, Mark B. McClellan
MIT Press In Garber, Alan (ed) "Frontiers in Health Policy Research" vol. 4 (2001)
Growth in Expenditures for Hospital Care for the Elderly: Cohort and Time Effects
Thomas E. MaCurdy, Alan M. Garber
University of Chicago Press In "Issues in Health Care in the U.S. and Japan", Alan Garber and S. Ogura S, ed. (2001)
Issues in Health Care in the US and Japan
Alan M. Garber, S. Ogura
University of Chicago Press (2001)
Frontiers in Health Policy Research
Alan M. Garber
Cambridge, MA: MIT Press vol. 7 (2001)
Advances in Cost-Effectiveness Analysis of Health Interventions
Alan M. Garber, AJ Culyer, JP Newhouse
North-Holland, in "Handbook of Health Economics" vol. 1 (2000)- Concise Review of the Cost-Effectiveness of Coronary Heart Disease Prevention, A
A.D. Brown, Alan M. Garber
Medical Clinics of North America vol. 84 (2000) 
Health Care and Information Technology: Growing Up Together
Sara J. Singer, Alain C. Enthoven, Alan M. Garber
Springer-Verlag (New York) in "Medical Informatics, Computer Application in Health Care, Second Edition", Shortliffe, et al, editors. (2000)
Cost-Effectiveness of Coronary Heart Disease Prevention Strategies in Adults
A.D. Brown, Alan M. Garber
Adis International Limited (New Zealand) in "Aspects of Hypertension Management", Mallarkey G, editor, Auckland. (1999)
Medical Care at the End of Life: Diseases, Treatment Patterns, and Costs
Alan M. Garber, Thomas E. MaCurdy, Mark B. McClellan
MIT Press (Cambridge, MA) in "Frontiers in Health Policy Research", A.M. Garber, ed. vol. 2 (1999)
Persistence of Medical Expenditures among Elderly Beneficiaries
Alan M. Garber, Thomas E MaCurdy, Mark B. McClellan
MIT Press in A. Garber, ed., "Frontiers in Health Policy Research" vol. 1 (1998)
Diagnosis and Medical Expenditures at the End of Life
Mark B. McClellan, Alan M. Garber, Thomas E. MaCurdy
University of Chicago Press in "Frontiers in the Economics of Aging", D. Wise, ed. (1998)
Cause-Specific Mortality among Medicare Enrollees
Jay Bhattacharya, Alan M. Garber, Thomas E MaCurdy
University of Chicago Press in "Inquiries in the Economics of Aging", Wise DA, ed. (1998)
To Comfort Always: Prospects of Expanded Social Responsibility for Long-Term Care
Alan M. Garber
University of Chicago Press In "Individual and Social Responsibility: Child Care, Education, Medical Care, and Long-Term Care in America", Fuchs VR, ed. (1996)
Theoretical Foundations of Cost-Effectiveness Analysis
Alan M. Garber, M.C. Weinstein, G.W. Torrance, M.S. Kamlet
Oxford University Press (New York) in "Cost-Effectiveness in Health and Medicine", Gold MR, Siegel JE, Russell LB, and Weinstein MC, eds (1996)
Paying for Evaluative Research
Alan M. Garber, Douglas K. Owens
National Academy Press (Washington, D.C.) in "Medical Innovations at the Crossroads, Vol. IV: Adopting New Medical Technology", Gelijns AC, and Dawkins HV, eds. (1994)
Forecasting Nursing Home Utilization of Elderly Americans
Alan M. Garber, Thomas E MaCurdy
University of Chicago Press in "Studies in the Economics of Aging", Wise DA, ed. (1994)
Financing Health Care for Elderly Americans in the 1990s
Alan M. Garber
University of Chicago Press in "Aging in the United States and Japan: Economic Trends", Noguchi Y, and Wise DA, eds. (1994)- Payment Source and Episodes of Institutionalization
Alan M. Garber, Thomas E. MaCurdy
University of Chicago Press in "New Directions in the Economics of Aging", Wise D, ed. (1992) 
Predicting Nursing Home Utilization among the High-Risk Elderly
Alan M. Garber, Thomas E. MaCurdy
University of Chicago Press in "Issues in the Economics of Aging", Wise DA, ed. (1990)- Pursuing the Links between Socioeconomic Factors and Health: Critique, Policy Implications, and Directions for Future Research
Alan M. Garber
Henry J. Kaiser Family Foundation (Menlo Park, CA) in "Pathways to Health: the Role of Social Factors", Bunker JP, Gomby DS, and Kehrer BH, eds. (1989) - Long-Term Care, Wealth, and Health of the Disabled Elderly Living in the Community
Alan M. Garber
University of Chicago Press in "The Economics of Aging", Wise DA, ed. (1989)